According to the Project on Government Oversight, the agency now depends on those fees for more than half its funding. The revolving door between the industry and the agency tasked with regulating that industry is also a concern. Gottlieb himself came straight from consultancies and board memberships with various pharmaceutical companies.
No comments:
Post a Comment